Organophosphorus compounds and carbamates as perilysosomal modifiers.
D000135:Acid Phosphatase / Q000378:metabolism; D000818:Animals; D002219:Carbamates / Q000494:pharmacology*; D002403:Cathepsins / Q000378:metabolism; D002855:Chromatography, Thin Layer; D006854:Hydrocortisone / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D008099:Liver / Q000166:cytology / Q000187:drug effects / Q000201:enzymology*; D008247:Lysosomes / Q000187:drug effects / Q000201:enzymology*; D008294:Malathion / Q000031:analogs & derivatives / Q000494:pharmacology*; D008297:Male; D063065:Organophosphonates / Q000494:pharmacology; D009943:Organophosphorus Compounds / Q000494:pharmacology*; D010261:Paraoxon / Q000494:pharmacology; D051381:Rats; D013395:Sucrose / Q000494:pharmacology; D013429:Sulfatases / Q000378:metabolism; D013997:Time Factors; D014461:Ultracentrifugation
D002219:Carbamates; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D013395:Sucrose; D000135:Acid Phosphatase; D013429:Sulfatases; D002403:Cathepsins; D010261:Paraoxon; D008294:Malathion; D006854:Hydrocortisone